157 related articles for article (PubMed ID: 19540285)
1. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells.
Novoselov AV; Rezaykin AV; Sergeev AG; Fadeyev FA; Grigoryeva JV; Sokolova ZI
Virus Res; 2012 Jun; 166(1-2):87-96. PubMed ID: 22445689
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.
Johansson ES; Xing L; Cheng RH; Shafren DR
J Virol; 2004 Nov; 78(22):12603-12. PubMed ID: 15507647
[TBL] [Abstract][Full Text] [Related]
4. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
5. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
Stuart AD; McKee TA; Williams PA; Harley C; Shen S; Stuart DI; Brown TD; Lea SM
J Virol; 2002 Aug; 76(15):7694-704. PubMed ID: 12097583
[TBL] [Abstract][Full Text] [Related]
6. Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells.
Chevaliez S; Balanant J; Maillard P; Lone YC; Lemonnier FA; Delpeyroux F
Virology; 2008 Nov; 381(2):203-14. PubMed ID: 18823925
[TBL] [Abstract][Full Text] [Related]
7. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.
Spiller OB; Goodfellow IG; Evans DJ; Almond JW; Morgan BP
J Infect Dis; 2000 Jan; 181(1):340-3. PubMed ID: 10608785
[TBL] [Abstract][Full Text] [Related]
8. Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.
Shafren DR; Dorahy DJ; Thorne RF; Kinoshita T; Barry RD; Burns GF
J Immunol; 1998 Mar; 160(5):2318-23. PubMed ID: 9498772
[TBL] [Abstract][Full Text] [Related]
9. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
10. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
11. Echovirus 6 strains derived from a clinical isolate show differences in haemagglutination ability and cell entry pathway.
Lévêque N; Norder H; Zreik Y; Cartet G; Falcon D; Rivat N; Chomel JJ; Hong SS; Lina B
Virus Res; 2007 Dec; 130(1-2):1-9. PubMed ID: 17566587
[TBL] [Abstract][Full Text] [Related]
12. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.
Powell RM; Schmitt V; Ward T; Goodfellow I; Evans DJ; Almond JW
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1707-13. PubMed ID: 9680134
[TBL] [Abstract][Full Text] [Related]
13. Studies of Echovirus 5 interactions with the cell surface: heparan sulfate mediates attachment to the host cell.
Israelsson S; Gullberg M; Jonsson N; Roivainen M; Edman K; Lindberg AM
Virus Res; 2010 Aug; 151(2):170-6. PubMed ID: 20466025
[TBL] [Abstract][Full Text] [Related]
14. Interaction of decay-accelerating factor with coxsackievirus B3.
Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
[TBL] [Abstract][Full Text] [Related]
15. Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells.
Sobo K; Rubbia-Brandt L; Brown TD; Stuart AD; McKee TA
J Virol; 2011 Dec; 85(23):12376-86. PubMed ID: 21917947
[TBL] [Abstract][Full Text] [Related]
16. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
[TBL] [Abstract][Full Text] [Related]
17. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity.
Kim MS; Racaniello VR
J Virol; 2007 Aug; 81(16):8648-55. PubMed ID: 17537857
[TBL] [Abstract][Full Text] [Related]
20. [Mapping of point mutations leading to loss of virus ECH011 affinity for receptor DAF (CD55)].
Rezaĭkin AB; Novoselov AB; Fadeev FA; Sergeev AG; Lebedev SB
Vopr Virusol; 2009; 54(1):41-4. PubMed ID: 19253731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]